These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23410672)

  • 1. Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits.
    Fournier N; Tuloup-Minguez V; Pourci ML; Thérond P; Jullian JC; Wien F; Leroy M; Dallongeville J; Paul JL; Leroy A
    Biochimie; 2013 Jun; 95(6):1278-87. PubMed ID: 23410672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.
    Hennuyer N; Poulain P; Madsen L; Berge RK; Houdebine LM; Branellec D; Fruchart JC; Fiévet C; Duverger N; Staels B
    Circulation; 1999 May; 99(18):2445-51. PubMed ID: 10318668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits.
    Flores-Castillo C; Luna-Luna M; Carreón-Torres E; López-Olmos V; Frías S; Juárez-Oropeza MA; Franco M; Fragoso JM; Vargas-Alarcón G; Pérez-Méndez Ó
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand white rabbits with exogenous hypercholesterolemia.
    Flores-Castillo C; Zamora-Pérez JÁ; Carreón-Torres E; Arzola-Paniagua A; Aguilar-Salinas C; López-Olmos V; Fragoso JM; Luna-Luna M; Rodríguez-Pérez JM; Franco M; Vargas-Alarcón G; Pérez-Méndez Ó
    Fundam Clin Pharmacol; 2015 Aug; 29(4):362-70. PubMed ID: 25982284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits.
    Zhao SP; Wu ZH; Hong SC; Ye HJ; Wu J
    Clin Chim Acta; 2006 Mar; 365(1-2):119-24. PubMed ID: 16185675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1.
    Lan D; Silver DL
    J Biol Chem; 2005 Jun; 280(24):23390-6. PubMed ID: 15837786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.
    Stuckey BG; Barrett PH; Wagner JM; Hampton RA; Chan DC; Brown SJ; Watts GF
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):497-501. PubMed ID: 20560981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.
    Rotllan N; Llaverías G; Julve J; Jauhiainen M; Calpe-Berdiel L; Hernández C; Simó R; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2011 Feb; 1811(2):104-10. PubMed ID: 21126601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate.
    Bouly M; Masson D; Gross B; Jiang XC; Fievet C; Castro G; Tall AR; Fruchart JC; Staels B; Lagrost L; Luc G
    J Biol Chem; 2001 Jul; 276(28):25841-7. PubMed ID: 11342537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
    Hong SC; Zhao SP; Wu ZH
    Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI.
    Corti R; Osende J; Hutter R; Viles-Gonzalez JF; Zafar U; Valdivieso C; Mizsei G; Fallon JT; Fuster V; Badimon JJ
    Atherosclerosis; 2007 Jan; 190(1):106-13. PubMed ID: 16600250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fibrate drugs on expression of ABCA1 and HDL biogenesis in hepatocytes.
    Hossain MA; Tsujita M; Gonzalez FJ; Yokoyama S
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):258-66. PubMed ID: 18356690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients.
    Franceschini G; Calabresi L; Colombo C; Favari E; Bernini F; Sirtori CR
    Atherosclerosis; 2007 Dec; 195(2):385-91. PubMed ID: 17109866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.
    Ballantyne CM; Miller M; Niesor EJ; Burgess T; Kallend D; Stein EA
    Am Heart J; 2012 Mar; 163(3):515-21, 521.e1-3. PubMed ID: 22424025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
    Kaur J; Reddy K; Balakumar P
    Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer protein.
    Lie J; Lankhuizen IM; Gross B; van Gent T; van Haperen R; Scheek L; Staels B; de Crom R; van Tol A
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):48-53. PubMed ID: 16298159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
    Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI.
    Nieland TJ; Shaw JT; Jaipuri FA; Maliga Z; Duffner JL; Koehler AN; Krieger M
    J Lipid Res; 2007 Aug; 48(8):1832-45. PubMed ID: 17533223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease.
    Zimetti F; Favari E; Cagliero P; Adorni MP; Ronda N; Bonardi R; Gomaraschi M; Calabresi L; Bernini F; Guardamagna O
    Atherosclerosis; 2015 Oct; 242(2):443-9. PubMed ID: 26291497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models.
    Ma K; Forte T; Otvos JD; Chan L
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):149-54. PubMed ID: 15539616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.